Arch Biopartners Inc. (ACHFF)
USD 1.1
(-7.56%)
USD 1.1
(-7.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.98 Million | 964.68 Thousand | 3.88 Million | 67.88 Thousand | 93.87 Thousand | - |
| Cost of Revenue | 2.11 Million | 1.46 Million | 4.03 Million | 2.19 Million | 1.49 Million | 1.5 Million |
| Gross Profit | -128.99 Thousand | -502.87 Thousand | -149.79 Thousand | -2.12 Million | -1.4 Million | -1.5 Million |
| Operating Expenses | 3.22 Million | 1.08 Million | 891.53 Thousand | 4.52 Million | 2.34 Million | 3.16 Million |
| Selling, General and Administrative Expenses | 2.72 Million | 772.61 Thousand | 1 Million | 2.56 Million | 770.67 Thousand | 1.73 Million |
| Research and Development Expenses | 1.94 Million | 1.27 Million | 3.77 Million | 1.95 Million | 1.57 Million | 1.43 Million |
| Other Expenses | -1.44 Million | - | - | - | -173.49 Thousand | -216.78 Thousand |
| Cost and Expenses | 5.24 Million | 1.08 Million | 891.53 Thousand | 4.52 Million | 2.34 Million | 3.16 Million |
| Operating Income | -3.35 Million | -1.38 Million | -1.16 Million | -4.63 Million | -2.36 Million | -3.23 Million |
| Interest Expense | 358.93 Thousand | 309.33 Thousand | 273.3 Thousand | 175.96 Thousand | 110.28 Thousand | 64.04 Thousand |
| Income Tax Expense | - | 636.85 Thousand | 36.74 Thousand | -30.33 Thousand | -61.57 Thousand | -97.09 Thousand |
| Earnings before Tax | -3.32 Million | -1.38 Million | -1.16 Million | -4.62 Million | -2.35 Million | -3.19 Million |
| Net Income | -3.32 Million | -1.38 Million | -1.16 Million | -4.62 Million | -2.35 Million | -3.19 Million |
| Earnings Per Share Basic | -0.05 | -0.02 | -0.02 | -0.08 | -0.04 | -0.06 |
| Earnings Per Share Diluted | -0.05 | -0.02 | -0.02 | -0.08 | -0.04 | -0.06 |
| Weighted Average Shares Outstanding | 62.46 Million | 62.15 Million | 61.32 Million | 59.92 Million | 58.64 Million | 57.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 62.46 Million | 62.15 Million | 61.32 Million | 59.92 Million | 58.64 Million | 57.02 Million |
| Gross Margin | -0.07 | -0.52 | -0.04 | -31.27 | -14.95 | - |
| EBIT Margin | -1.50 | -1.12 | -0.23 | -65.67 | -23.99 | - |
| Profit Margin | -1.68 | -1.44 | -0.30 | -68.18 | -25.11 | - |
| EBITDA | -2.97 Million | -1.08 Million | -891.53 Thousand | - | - | - |
| Earnings Before Tax Margin | -1.69 | -1.44 | -0.30 | -68.26 | -25.16 | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | 2.18 Million | 298.14 Thousand | 1.98 Million | -1.09 Million | 116.37 Thousand |
| Cost of Revenue | 473.1 Thousand | 2.74 Million | 169.73 Thousand | 2.11 Million | 1.83 Million | 312.88 Thousand |
| Gross Profit | -473.1 Thousand | -561.26 Thousand | 128.41 Thousand | -128.99 Thousand | -2.93 Million | -196.51 Thousand |
| Operating Expenses | 389.82 Thousand | 1.05 Million | 1 Million | 5.24 Million | -516.88 Thousand | 474.3 Thousand |
| Selling, General and Administrative Expenses | 280.92 Thousand | 429.34 Thousand | 865.87 Thousand | - | 195.62 Thousand | 250.31 Thousand |
| Research and Development Expenses | 440.27 Thousand | 2.7 Million | 135.51 Thousand | - | -1.92 Million | 289.32 Thousand |
| Other Expenses | -331.36 Thousand | - | - | - | - | - |
| Cost and Expenses | 862.93 Thousand | 1.05 Million | 1 Million | 5.24 Million | -516.88 Thousand | 474.3 Thousand |
| Operating Income | -862.93 Thousand | -1.14 Million | -1 Million | -5.24 Million | 401.25 Thousand | -577.42 Thousand |
| Interest Expense | 95.28 Thousand | 88.68 Thousand | 88.69 Thousand | 358.93 Thousand | 115.63 Thousand | 103.11 Thousand |
| Income Tax Expense | -658.74 Thousand | -4072.00 | -686.2 Thousand | -264.08 Thousand | -16.53 Thousand | 142.7 Thousand |
| Earnings before Tax | -884.56 Thousand | -1.14 Million | -783.25 Thousand | -3.59 Million | 244.28 Thousand | -450.78 Thousand |
| Net Income | -884.56 Thousand | -1.14 Million | -783.25 Thousand | -3.32 Million | 244.28 Thousand | -450.78 Thousand |
| Earnings Per Share Basic | -0.01 | -0.02 | -0.01 | - | 0.00 | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.02 | -0.01 | - | 0.00 | -0.01 |
| Weighted Average Shares Outstanding | 62.75 Million | 62.75 Million | 62.46 Million | 62.46 Million | 62.59 Million | 62.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 62.75 Million | 62.75 Million | 62.46 Million | 62.46 Million | 62.59 Million | 62.24 Million |
| Gross Margin | - | -0.26 | 0.43 | -0.07 | 2.67 | -1.69 |
| EBIT Margin | - | -0.48 | -3.36 | - | -0.49 | -4.08 |
| Profit Margin | - | -0.53 | -2.63 | -1.68 | -0.22 | -3.87 |
| EBITDA | -767.65 Thousand | -1.05 Million | -1 Million | - | 533.41 Thousand | -474.3 Thousand |
| Earnings Before Tax Margin | - | -0.52 | -3.36 | -2.64 | -0.37 | -4.96 |
603583
CLSA3
FLU
KSL
GNGR
CLIUF